Antiretroviral Therapy, Highly Active

Antiviral Agents
A Lower Baseline CD4/CD8 T-Cell Ratio Is Independently Associated with Immunodiscordant Response to Antiretroviral Therapy in HIV-Infected Subjects
I. Rosado-Sánchez, I. Herrero-Fernández, A. I. Álvarez-Ríos, M. Genebat, M. A. Abad-Carrillo, E. Ruiz-Mateos, F. Pulido, J. González-García, M. Montero, E. Bernal-Morell, F. Vidal, M. Leal, Y. M. Pacheco
Antiviral Agents
Upregulation of Apoptosis Pathway Genes in Peripheral Blood Mononuclear Cells of HIV-Infected Individuals with Antiretroviral Therapy-Associated Mitochondrial Toxicity
Yram Foli, Musie Ghebremichael, Min Li, Elijah Paintsil
Antiviral Agents
Drug Resistance Mutation Profile and Accumulation Kinetics in Human Immunodeficiency Virus-Positive Individuals Infected with Subtypes B and F Failing Highly Active Antiretroviral Therapy Are Influenced by Different Viral Codon Usage Patterns
A. Waléria-Aleixo, A. N. Martins, M. B. Arruda, R. M. Brindeiro, R. M. Da-Silva, F. F. Nobre, D. B. Greco, A. Tanuri
Antiviral Agents
Cytokine Expression in the Colonic Mucosa of Human Immunodeficiency Virus-Infected Individuals before and during 9 Months of Antiretroviral Therapy
Hubert Schulbin, Hagen Bode, Hartmut Stocker, Wolfgang Schmidt, Thomas Zippel, Christoph Loddenkemper, Elisabeth Engelmann, Hans-Jörg Epple, Keikawus Arastéh, Martin Zeitz
and and Reiner Ullrich for the Kompetenznetz HIV/AIDS Germany
AUTHOR'S CORRECTION
Population Pharmacokinetics of Tenofovir in Human Immunodeficiency Virus-Infected Patients Taking Highly Active Antiretroviral Therapy
Vincent Jullien, Jean-Marc Tréluyer, Elisabeth Rey, Patrick Jaffray, Anne Krivine, Laurence Moachon, Agnès Lillo-Le Louet, Anne Lescoat, Nicolas Dupin, Dominique Salmon, Gérard Pons, Saïk Urien
Antiviral Agents
Interpretation of Genotype and Pharmacokinetics for Resistance to Fosamprenavir-Ritonavir-Based Regimens in Antiretroviral-Experienced Patients
Isabelle Pellegrin, Dominique Breilh, Gaelle Coureau, Sébastien Boucher, Didier Neau, Patrick Merel, Denis Lacoste, Hervé Fleury, Marie-Claude Saux, Jean-Luc Pellegrin, Estibaliz Lazaro, François Dabis, Rodolphe Thiébaut
and for the ANRS Co3 Aquitaine Cohort
Pharmacology
Population Pharmacokinetics of Tenofovir in Human Immunodeficiency Virus-Infected Patients Taking Highly Active Antiretroviral Therapy
Vincent Jullien, Jean-Marc Tréluyer, Elisabeth Rey, Patrick Jaffray, Anne Krivine, Laurence Moachon, Agnès Lillo-Le Louet, Anne Lescoat, Nicolas Dupin, Dominique Salmon, Gérard Pons, Saïk Urien
Antiviral Agents
Comparison of the Dynamics of Resistance-Associated Mutations to Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors after Cessation of Antiretroviral Combination Therapy
Marc Wirden, Constance Delaugerre, Anne Genevieve Marcelin, Nadine Ktorza, Hocine Ait Mohand, Stephanie Dominguez, Luminita Schneider, Jade Ghosn, Michele Pauchard, Dominique Costagliola, Christine Katlama, Vincent Calvez
Antiviral Agents
Evolution of Human Immunodeficiency Virus Type 1 (HIV-1) Resistance Mutations in Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) in HIV-1-Infected Patients Switched to Antiretroviral Therapy without NNRTIs
Véronique Joly, Diane Descamps, Gilles Peytavin, Fatiha Touati, France Mentre, Xavier Duval, Séverine Delarue, Patrick Yeni, Françoise Brun-Vezinet
Letter to the Editor
High Impact of an Expanded Restriction Fragment Length Polymorphism Assay on Detection of Ganciclovir-Resistant UL97 Mutants of Human Cytomegalovirus
Tobias Eckle, Gerhard Jahn, Klaus Hamprecht

Main menu

User menu

Search

Antiretroviral Therapy, Highly Active

Pages